Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 11.84B | 11.69B | 11.98B | 11.55B | 10.44B | 10.06B |
Gross Profit | 6.71B | 6.59B | 6.82B | 6.58B | 6.10B | 5.77B |
EBITDA | 1.38B | 1.44B | 1.66B | 1.52B | 1.23B | 1.61B |
Net Income | 606.45M | 716.89M | 815.98M | 752.57M | 522.25M | 840.87M |
Balance Sheet | ||||||
Total Assets | 14.75B | 15.37B | 15.76B | 15.14B | 14.36B | 14.87B |
Cash, Cash Equivalents and Short-Term Investments | 9.22B | 9.68B | 9.89B | 9.01B | 8.23B | 8.30B |
Total Debt | 0.00 | 0.00 | 0.00 | 209.00K | 1.32M | 4.87M |
Total Liabilities | 3.15B | 3.39B | 4.04B | 3.81B | 3.39B | 3.59B |
Stockholders Equity | 11.60B | 11.97B | 11.73B | 11.33B | 10.97B | 11.28B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 424.92M | 1.28B | 1.24B | 171.51M | 128.76M |
Operating Cash Flow | 0.00 | 429.11M | 1.46B | 1.49B | 644.88M | 586.57M |
Investing Cash Flow | 0.00 | -123.66M | 12.01M | -201.67M | 69.33M | -95.11M |
Financing Cash Flow | 0.00 | -522.74M | -513.51M | -513.58M | -777.32M | -502.18M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | ¥13.65B | 9.36 | 3.83% | 10.04% | 99.20% | ||
82 Outperform | ¥13.78B | 10.13 | 0.41% | -54.70% | -73.05% | ||
80 Outperform | ¥15.33B | 23.27 | 1.00% | 7.42% | 10.13% | ||
79 Outperform | ¥13.98B | 10.79 | 3.75% | 2.13% | 7.67% | ||
68 Neutral | ¥13.59B | 20.05 | 3.67% | -2.98% | -31.07% | ||
63 Neutral | $34.70B | 5.15 | -11.38% | 1.67% | 5.54% | -17.15% | |
59 Neutral | ¥82.33B | ― | ― | 32.00% | 55.33% |